A new study by GlobalData looked at brand oral antidiabetic drugs (OADs) and found that sharing negotiated rebates with patients in commercial health plans at the pharmacy counter can help lower costs, improve adherence and reduce health disparities. This common-sense solution can help us build a more affordable and equitable health care system and help avoid nearly 700 premature deaths each year.